论文部分内容阅读
目的 :了解可溶性肿瘤坏死因子受体 -Ⅰ (sTNFR -Ⅰ )在消化道恶性肿瘤患者中的临床意义。方法 :应用双抗体夹心ELISA法 ,对 37例食管癌、4 1例胃癌、30例大肠癌患者血清sTNFR -Ⅰ水平进行了检测。结果 :三组肿瘤患者血清sTNFR -Ⅰ水平显著高于对照组 ,且随肿瘤临床病理分期增加而增高 ,有转移者 ,显著高于无转移者。手术切除肿瘤后sTNFR -Ⅰ水平下降 ,肿瘤复发时 ,sTNFR -Ⅰ水平上升。结论 :检测血清sTNFR -Ⅰ水平有助于消化道恶性肿瘤患者的诊断及预后判断。
Objective : To understand the clinical significance of soluble tumor necrosis factor receptor-I (sTNFR-I) in patients with digestive tract malignancy. METHODS: Serum sTNFR-I levels were detected in 37 cases of esophageal cancer, 41 cases of gastric cancer, and 30 cases of colorectal cancer by double antibody sandwich ELISA. RESULTS: Serum sTNFR-I levels were significantly higher in the three groups of tumor patients than in the control group, and increased with the increase of the clinical pathological stage of the tumor. Those with metastases were significantly higher than those without metastasis. After surgical removal of the tumor, the level of sTNFR-I decreased, and when the tumor relapsed, the level of sTNFR-I increased. Conclusion : The detection of serum sTNFR-I level is helpful for the diagnosis and prognosis of patients with gastrointestinal cancer.